{
  "trial_id": "NCT02884141",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Patient with renal or craniocervical fibromuscular dysplasia diagnosed during the 4",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Who understood and signed inform consent form",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Affiliated to the French health insurance system",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Patient with renal or craniocervical atherosclerosis, or inflammatory vascular disease as dominant pathological features",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Patient with renal or craniocervical arteries dissection or aneurysm without any other evidence of fibromuscular dysplasia",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "74M hx of CAD s/p CABG, EF 60% prior CVA (no residual deficits), HTN, HL, DMII, Moderate to Severe PVD was referred to cardiology for evaluation of PVD...",
  "_meta": {
    "topic_id": "5",
    "trial_id": "NCT02884141",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}